David Dintenfass's most recent trade in Humana Inc. was a trade of 4,360 Humana Common done . Disclosure was reported to the exchange on Feb. 21, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Humana | David E. Dintenfass | President, Enterprise Growth | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 4,360 | 16,234 (0%) | 0% | 0 | Humana Common | |
Humana | David E. Dintenfass | President, Enterprise Growth | Payment of exercise price or tax liability using portion of securities received from the company at price $ 258.58 per share. | 21 Feb 2025 | 1,175 | 11,874 (0%) | 0% | 258.6 | 303,826 | Humana Common |
Humana | David Dintenfass | President, Enterprise Growth | 15 Dec 2024 | 261 | 13,049 (0%) | 0% | 271.7 | 70,907 | Humana Common | |
Humana | David Dintenfass | President, Enterprise Growth | 21 Feb 2024 | 51,389 | 51,389 | - | - | Options | ||
Humana | Dintenfass David | President, Enterprise Growth | 21 Feb 2024 | 13,310 | 13,310 (0%) | 0% | 0 | Humana Common |